Various wound conditions account for millions of deaths worldwide each year and trigger tremendous healthcare costs – more than 4 billion EUR a year in USA and Europe. It accounts for almost 4% of total health system costs, and this proportion is increasing, thus representing a significant and growing challenge to our healthcare systems.

Any damage to the skin barrier imposes a risk of infection and requires anti-infective treatment. Antimicrobial resistance (AMR) to antibiotics increases, and other anti-infective treatments available have various negative side-effects. Therefore, new cost-efficient non-antibiotic treatments are needed.